Key Documents

View All Documentation

327484

Platinum

Name: Platinum
Brand: ALDRICH

shot, ≤3 mm, ≥99.9% trace metals basis

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

CAS Number:

7440-06-4

Molecular Weight:

195.08

NACRES:

NA.23

PubChem Substance ID:

24859665

UNSPSC Code:

12141734

EC Number:

231-116-1

MDL number:

MFCD00011179

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Quality Level

100

assay

≥99.9% trace metals basis

form

shot

composition

reaction suitability

core: platinum

resistivity

10.6 μΩ-cm, 20°C

particle size

≤3 mm

bp

3827 °C (lit.)

mp

1772 °C (lit.)

density

21.45 g/cm³ (lit.)

SMILES string

[Pt]

InChI

1S/Pt

InChI key

BASFCYQUMIYNBI-UHFFFAOYSA-N

Description

Application

Platinum shot may be used in the preparation of (La_xCe_1-x)_1.33Pt₄Ga₁₀(0≤ x ≤1) single crystals, a potential non Fermi-liquid (NFL).

Storage Class

13 - Non Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Synthesis, structure, and magnetic behavior of (LaxCe 1- x) 1.33 Pt 4 Ga 10 (0? x? 1).

Macaluso, et al.

J. Alloy Compounds, 600, 193-198 (2014)

Upper eyelid postseptal weight placement for treatment of paralytic lagophthalmos.

Shai Rozen et al.

Plastic and reconstructive surgery, 131(6), 1253-1265 (2013-05-30)

Left untreated, paralytic lagophthalmos may result in corneal dryness, ulcerations, and subsequent blindness. The most common nondynamic surgical solution is upper eyelid weight placement in a superficial, pretarsal pocket, carrying the risk of visibility, extrusion, and entropion. The authors present

Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation.

Loris De Cecco et al.

PloS one, 8(3), e58849-e58849 (2013-03-14)

We recently reported that peritumoral CpG-ODN treatment, activating TLR-9 expressing cells in tumor microenvironment, induces modulation of genes involved in DNA repair and sensitizes cancer cells to DNA-damaging cisplatin treatment. Here, we investigated whether this treatment induces modulation of miRNAs

View All Related Papers

Global Trade Item Number

SKU	GTIN
327484-1G	04061826662328